State Street SPDR S&P Biotech ETF (XBI)
154.50
+1.49
(+0.97%)
USD |
NYSEARCA |
Aug 06, 16:00
155.59
+1.09
(+0.71%)
After-Hours: 06:50
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.35% | -0.04% | 10.09B | 8.876M |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.09% | 43.00% | 1.121B |
Basic Info
| Investment Strategy | |
| The Fund seeks to replicate as closely as possible the performance of an index derived from the biotechnology segment of a U.S. total market composite index. The Fund uses a passive management strategy designed to track the total return performance of the S&P Biotechnology Select Industry Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Small Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | State Street Investment Management |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of August 07, 2026.
Asset Allocation
As of June 30, 2026.
| Type | % Net |
|---|---|
| Cash | 0.02% |
| Stock | 99.97% |
| Bond | 0.02% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | -0.01% |
Basic Info
| Investment Strategy | |
| The Fund seeks to replicate as closely as possible the performance of an index derived from the biotechnology segment of a U.S. total market composite index. The Fund uses a passive management strategy designed to track the total return performance of the S&P Biotechnology Select Industry Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Small Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | State Street Investment Management |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |